CSL Ltd.

Pharmaceuticals
Australia
Executive 1Mr. Paul Perreault, Chief Executive Officer; Managing Director | Chief Executive Officer; Managing Director
Executive 2Gordon Naylor, MBA, Chief Financial Officer; | Division Officer; Chief Executive Officer; Preside
Earnings Per Share Growth (%)10.70%
Cost of Goods Sold (US$ Millions)$2,604
Current Liabilities (US$ Millions)$845
Total Assets (US$ Millions)$3,208
Long Term Debt (Millions)$1,885
Return on Equity43.47%
Revenue (US$ Millions)$5,524
Total Company Assets$6,278
Revenue Growth (%)7.70%
Net Income (US$ Millions)$1,307
Earnings Per Share (US$)$2.69
Total Equity (US$ Millions)$3,162
Profit Margin (%)23.66%
Debt To Equity Ratio (%)0.60%
Inventories (Millions)$1,645